BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Pharmica, which develops and manufactures pharmaceutical and biopharmaceutical products on a contract basis, recently received more good news from the Food and Drug Administration (FDA). The company earned another commercial approval from the FDA and did so with the FDA waiving the otherwise required pre-approval inspection. “We are grateful for the confidence shown in our facilities by the waiving of the inspection and are especially pleased that the quick approval will allow this drug to make it to patients in need. We will continue to work with the FDA to ensure that future clients experience the same efficient approval process,” said Tedd Green, president of Cook Pharmica.